Gilead Sciences Inc. (GILD34)
Bovespa
Real-time Data
01:00 PM
Day's Range
62.2352 wk Range
48.98Overview - GILD34 - Gilead Sciences Inc.
Key Statistics
Valuation
Enterprise Value
4.92T
P/E (Trailing)
‪17.78‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪30.60‬
Price / Book
‪1.28‬
EV / EBITDA
‪65.55‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
14.90B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪56.50‬
200-Day Avg
‪57.84‬
Dividends
Payout Ratio
‪30.21%‬
Frequency
Quarterly
Peers - GILD34 - Gilead Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on Bovespa.
- GILD34BovespaGilead Sciences Inc.825.34BMarket Cap+5.92%52-week change18.11P/E (Trailing)‪30.99%‬Profit Margin
- ABBV34BovespaAbbVie Inc.2.40TMarket Cap+17.65%52-week change74.19P/E (Trailing)‪9.80%‬Profit Margin
- MRCK34BovespaMerck & Co. Inc.1.64TMarket Cap+29.27%52-week change36.90P/E (Trailing)‪13.58%‬Profit Margin
- N1VS34BovespaNovartis AG1.50TMarket Cap+14.14%52-week change21.88P/E (Trailing)‪23.92%‬Profit Margin
- A1ZN34BovespaAstraZeneca PLC Sponsored BDR1.36TMarket Cap+8.41%52-week change25.52P/E (Trailing)‪17.18%‬Profit Margin
- PFIZ34BovespaPfizer Inc.710.60BMarket Cap-13.79%52-week change18.22P/E (Trailing)‪11.83%‬Profit Margin
- BMYB34BovespaBristol-Myers Squibb Company Depositary Receipt600.98BMarket Cap+9.73%52-week change15.88P/E (Trailing)‪15.00%‬Profit Margin
Profile Summary - GILD34 - Gilead Sciences Inc.
About
Gilead Sciences Inc. is a biopharmaceutical company renowned for its innovative research and development in the healthcare sector. The company primarily focuses on developing antiviral drugs for the treatment of HIV, hepatitis B and C, and influenza, among other viral infections. One of its most significant…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
